FULL GENOME COVERAGE NOW AVAILABLE
Assay Verification and Ongoing Performance Monitoring for Routine Patient Testing
TECHNOPATH partners with Seracare to provide a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their SARS-CoV-2 assay results.
AccuPlex™ SARS-CoV-2 Verification Panel is optimised for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. The product contains positive materials including the full SARS-CoV-2 viral genome, and negative materials targeting the human RNase P gene.
AccuPlex™ SARS-CoV-2 Reference Material Kit is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. The product is available in versions that offer different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS‐CoV‐2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene.
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully-extractable with a real viral protein coat; serves as a full-process reference material
- Compatible with assays targeting CDC and WHO consensus sequences
- Includes negative reference material for targeting sequences for the human RNAse P gene
- 2 year stability at 2 – 8°C
- Customisable to sequences of interest to meet unique assay design requirements
